AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today new clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA’s platform immunotherapy targeting cancer stem cells. Blood...
Cyxone (publ), a Swedish biotech in autoimmune diseases, today submitted an application to the Central Ethics Committee (CEC) in Poland for permission to start a clinical phase IIb trial with its drug candidate Rabeximod, which is in development for the treatment of...
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process CAMBRIDGE, Mass., July 8, 2019 /PRNewswire/ — A new study published in the...
Geneva, Switzerland and Boston, MA – July 8, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive...
BOSTON and SOPHIA ANTIPOLIS, France, July 8, 2019 /PRNewswire/ — Median Technologies, The Imaging Phenomics Company® (ALMDT: PA) and AG Mednet have renewed their partnership to use AG Mednet’s global infrastructure for the collection, QC and delivery of...
Collaboration Achieves First Significant Milestone with Successful Execution of Technology Transfer Additional Significant Milestones, Including Submission of the Investigational New Drug (IND) Application Which is Expected by the End of the Third Quarter TEL AVIV,...
Email
Text